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Two models are proposed to explain Notch function
during helper T (Th) cell differentiation. One argues
that Notch instructs one Th cell fate over the other,
whereas the other posits that Notch function is
dictated by cytokines. Here we provide a detailed
mechanistic study investigating the role of Notch in
orchestrating Th cell differentiation. Notch neither in-
structed Th cell differentiation nor did cytokines
direct Notch activity, but instead, Notch simulta-
neously regulated the Th1, Th2, and Th17 cell genetic
programs independently of cytokine signals. In addi-
tion to regulating these programs in both polarized
and nonpolarized Th cells, we identified Ifng as a
direct Notch target. Notch bound the Ifng CNS-22
enhancer, where it synergized with Tbet at the pro-
moter. Thus, Notch acts as an unbiased amplifier of
Th cell differentiation. Our data provide a paradigm
for Notch in hematopoiesis, with Notch simulta-
neously orchestrating multiple lineage programs,
rather than restricting alternate outcomes.
INTRODUCTION
Naive CD4+ T cells are responsible for controlling both intracel-
lular and extracellular infections. Although developmentally
mature, naive CD4+ T cells require activation in order to adopt
one of several effector programs, including the interferon-g
(IFN-g) producing T helper 1 (Th1) cell, the interleukin-4 (IL-4)
producing T helper 2 (Th2) cell, and the IL-17 producing Th17
cell. These three Th subsets serve different functions. Th1 cells
are necessary to combat intracellular pathogens and mediate
autoimmune diseases, such as graft-versus-host disease
(GVHD). Th2 cells are essential effectors during parasitic hel-
minth infection and also mediate airway hypersensitivity and
allergic inflammation. Th17 cells are critical for controlling extra-
cellular bacterial and fungal infections and are also responsible
for autoimmunity (Coghill et al., 2011).
The T helper cell program adopted by a naive CD4+ T cell is in-
structed both by extracellular molecules, such as cytokines, and148 Immunity 39, 148–159, July 25, 2013 ª2013 Elsevier Inc.intracellular molecules, such as the Th1, Th2, and Th17 cell tran-
scription factors, Tbet, GATA-3, and Rorgt respectively. Notch
has also been proposed to mediate Th cell differentiation, where
it functions to relay intercellular signals from the membrane to
the nucleus in order to instruct Th cell differentiation (Amsen
et al., 2009).
Notch signaling initiates when a Notch ligand interacts with a
Notch receptor leading to a series of proteolytic cleavages that
release the Notch intracellular domain (ICN) from the cell mem-
brane; whereupon it translocates to the nucleus and forms a
transcriptional activation complex with the transcription factor
RBPJ and a member of the Mastermind-like (MAML) family (Ko-
pan and Ilagan, 2009). Compelling cases have been made for
Notch involvement in both Th1 and Th2 cell differentiation.
Manipulating Notch ligand-mediated stimulation of CD4+
T cells preferentially instructed Th1 or Th2 cell programs, sug-
gesting that individual Notch ligands have different instructive
capacities (Amsen et al., 2004; Maekawa et al., 2003; Okamoto
et al., 2009). Loss-of-function studies also demonstrated that
Notch instructed the Th1 cell program in vitro and promoted
the CD4+ T cell IFN-g response in a murine GVHD model (Minter
et al., 2005; Skokos and Nussenzweig, 2007; Zhang et al., 2011).
In contrast, other reports showed that Notch was required to
instruct the Th2 but not the Th1 cell program (Amsen et al.,
2009; Amsen et al., 2004; Fang et al., 2007; Kubo, 2007; Tu
et al., 2005). More recently, Notch was found to regulate the
Th17 cell signature genes Il17a and Rorc, suggesting that the bi-
potential instructional model may not be sufficient to explain
Notch function in Th cell differentiation (Keerthivasan et al.,
2011; Mukherjee et al., 2009). While the instructional model
posits that ligands direct Notch function during Th cell differen-
tiation, an alternativemodel argues that Notch target gene selec-
tivity is dictated by upstream cytokine signals (Ong et al., 2008).
Despite the differences between these models, both contend
that Notch has the capacity to discriminately activate different
Th cell programs. Thus, the paradox remains: how can such a
basic signaling module selectively drive the differentiation of
multiple distinct lineages?
In order to address these controversies, we investigated the
molecular mechanisms by which Notch orchestrates Th cell dif-
ferentiation. We find that Notch neither initiates a single helper
T cell program nor do cytokine signals dictate the outcome of
Notch signaling. Instead, Notch simultaneously regulates the
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Figure 1. Notch Signaling Is Dispensable for Th2 Initiation during Trichuris muris Infection
(A) At day 21, MLN from T. muris infected CC, CCD, and CCD + anti-IFN-g mice were stimulated with anti-CD3 for 72 hr and cytokine levels were measured
by ELISA.
(B) Serum T. muris specific IgG1 and IgG2c and (C) total IgE were measured by ELISA from infected mice, at day 21.
(D) Goblet cells, dark staining, in gut sections were detected by mucin staining.
(E) Cecal worm burdens at day 21 after infection. *p < 0.05. Data are represented as mean ± SEM.
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Notch Functions in Helper T CellsTh1, Th2, and Th17 genetic programs independently of cytokine
signals. Even under strong polarizing conditions, Notch directly
regulates critical effectors of Th1, Th2, and Th17 cell differentia-
tion. In addition to Il4, Tbx21,Gata3-1a, Il17a, andRorc, we iden-
tify Ifng as a direct Notch target. Notch regulates Ifng by binding
to a highly conserved RBPJ motif in the Ifng CNS-22 and syner-
gizes with T-bet activity at the Ifng promoter. These data support
a model in which Notch integrates and amplifies cytokine-
derived signals, instead of acting as a transcriptional driver or
a downstream accessory of cytokines. Not only do our data unify
the disparate data on Notch and Th cell differentiation but they
also offer an alternative view of Notch function in the hematopoi-
etic system, whereby Notch reinforces multiple fates rather than
restricting alternate outcomes.
RESULTS
Notch Signaling Is Dispensable for Th2 Cell Initiation
during Trichuris muris Infection
We previously showed that CD4+ T cells expressing the pan-
Notch inhibitor dominant-negative mastermind (DNMAML),
which binds the Notch:RBPJ dimer but fails to transactivate,
do not mount an effective Th2 cell response against the intestinalhelminth Trichuris muris and fail to clear infection with normal
kinetics (Tu et al., 2005). The outcome of T. muris infection
depends on the balance of Th1 cells, which are responsible for
chronic infection, and Th2 cells, which are required for parasite
expulsion and resistance to infection (Artis et al., 2002; Blackwell
and Else, 2001; Cliffe and Grencis, 2004; Cliffe et al., 2005; Else
et al., 1994). Although Notch was necessary for optimal Th2 cell-
dependent immunity in this infection model, it remained unclear
whether Notch was essential to initiate Th2 cell differentiation or
instead was required to generate the optimal balance of Th1 and
Th2 cells. To test this, we infected Cd4-Cre (CC) and Cd4-Cre3
DNMAMLFL/FL (CCD) mice with T. muris, and CCD mice were
treated with neutralizing anti-IFN-g mAbs for the duration of
infection. If Notchwere required to initiate Th2 cell differentiation,
anti-IFN-g treated CCD mice should remain susceptible to
T. muris infection. Alternatively, if Notch played a greater role
in generating an optimal Th2 cell response, then IFN-g blockade
should be sufficient to relieve any inhibitory effects of a subopti-
mal Th1:Th2 ratio on infection-induced Th2 differentiation.
As expected, mesenteric lymph node cells from the control CC
mice displayed robust IL-4, IL-5, and IL-13 responses upon
restimulation (Figure 1A). Consistent with our previous findings,
CCD mice demonstrated impaired Th2 cell cytokine responsesImmunity 39, 148–159, July 25, 2013 ª2013 Elsevier Inc. 149
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Notch Functions in Helper T Cells(Figure 1A). In contrast, CCDmice receiving anti-IFNgmAb treat-
ment restored IL-4, IL-5, and IL-13 production and diminished
IFN-g production, suggesting that Notch was not required to
initiate Th2 responses (Figure 1A). In agreement with the cyto-
kine data, CCD mice displayed an impaired protective
T. muris-specific immunoglobulin G1 (IgG1) response and an
elevated nonprotective T. muris-specific IgG2c response. In
contrast, anti-IFN-g mAb-treated CCD mice recovered parasite
specific IgG1 and showed a trend toward decreased IgG2c (Fig-
ure 1B). Similarly, while CCD mice displayed decreased serum
IgE, anti-IFN-gmAb treatment restored this response (Figure 1C).
Furthermore, histologic analysis of intestinal sections revealed
that anti-IFN-g mAb treatment rescued the goblet cell mucin
response in CCD mice (Figure 1D). Finally, anti-IFN-g mAb
treatment restored the ability of CCD mice to expel parasites
with kinetics comparable to infected CC control mice by
21 days after infection (Figure 1E). Collectively, these data
demonstrate that Notch is not essential to initiate Th2 cell
responses in vivo and instead suggest that Notch functions to
optimize the response.
Persistent Notch Signaling Is Required to Maintain the
Th1 and Th2 Cell Programs
To further test whether Notch is required to maintain an optimal
Th2 cell response, we investigated the effect of inhibiting Notch
subsequent to Th2 cell differentiation. For these studies, we
developed an in vitro differentiation system in which Notch could
be inhibited at different times by addition of a gamma secretase
inhibitor (GSI) following activation of CD4+ T cells. This system
also provided the opportunity to test the requirement for Notch
in Th1 cell differentiation. Importantly, Notch inhibition by GSI
did not affect T cell activation, proliferation, or cell numbers,
even after prolonged exposure (see Figures S1A–S1C available
online), in contrast to a recent report (Helbig et al., 2012). To
look at Notch specific effects and exclude autocrine cytokine
effects, we cultured cells in the presence of neutralizing IL-4
and IFN-g antibodies.
To test whether Notch was required after initiation to maintain
both the Th1 and Th2 cell programs, we activated naive CD4+
T cells in the presence of irradiated splenocytes. After 5 days,
cells were restimulated and treated with either DMSO or GSI
and left in culture for an additional 2 days (day 7) before harvest.
When looking at Th1 cell signature genes, both messenger RNA
(mRNA) and protein for Tbet and IFN-g were significantly lower
after 2 days of GSI treatment (Figures 2A–2C). Similarly, GSI
decreased mRNA and protein expression of the Th2 signature
genes, Gata3 and Il4 (Figures 2A–2C).
While our data show that persistent Notch signaling is required
to maintain the Th1 and Th2 cell programs after initiation, it
remained unclear whether the activity of Notch on Th1 and Th2
cell targets was restricted to early patterning events or whether
Notch was capable of reactivating target genes late after T cell
stimulation. To address this, naive CD4+ T cells were activated
in the presence of either DMSO or GSI, under neutralizing condi-
tions. After 5 days, cells were washed, restimulated, and
returned to either DMSO or GSI to test whether cells previously
treated with GSI could recover cytokine and transcription factor
expression. Whereas cells treated with GSI for all 7 days of
culture showed impaired T-bet and IFN-g induction, cells treated150 Immunity 39, 148–159, July 25, 2013 ª2013 Elsevier Inc.with GSI only for the first round of stimulation recovered T-bet
and IFN-g responses (Figures 2D–2F). Similarly, IL-4 and
GATA-3 expression decreased when cells were treated with
GSI for all 7 days and recovered when GSI was removed (Figures
2D–2F). Our findings indicate that Notch is capable of promoting
Th1 and Th2 signature gene expression both at early and late
time points following stimulation and that inhibiting Notch at
either the beginning of T cell stimulation or at later time points
represses both Th1 and Th2 cell differentiation. Furthermore,
we repeatedly observed that expression of both Th1 and Th2
cell program genes and proteins were suppressed in the
same population upon Notch inhibition, suggesting that Notch
concurrently regulates both programs. Collectively, these
data show that Notch functions in Th cell differentiation do not
require upstream signals from polarizing cytokines and demon-
strate that the activity of Notch on its targets is not kinetically
restricted.
Notch Concurrently Regulates Both the Th1 and Th2
Programs
Although both Th1 and Th2 cell signature geneswere sensitive to
GSI, it was important to show that the effects were Notch-
specific because GSI has Notch-independent effects. Further-
more, Notch-independent, Presenilin-dependent effects on
cytokine production were reported for both Th1 and Th2 cell
types (Ong et al., 2008). To test whether the changes we
observed were Notch-specific, we utilized mice containing two
floxed alleles of dominant-negative mastermind (DNMAMLFL/FL),
a potent and specific GFP-tagged pan-Notch inhibitor.
Tat-Cre-treated YFPFL/FL and DNMAMLFL/FL naive CD4+
T cells were stimulated under neutralizing conditions. Use of
the Tat-Cre peptide to acutely induce DNMAML expression
minimized potential compensation for Notch signaling by other
pathways. As expected, YFP+ T cells produced IL-4 and IFN-g
(Figure 3A). Consistent with observations with GSI treatment,
DNMAML expressing T cells displayed a marked reduction in
the fraction of cells that produced IL-4 and IFN-g confirming
that Notch regulates both IL-4 and IFN-g production in the
same cell population (Figure 3A). In contrast to the GSI data,
analysis of T-bet and GATA-3 protein in DNMAML-expressing
cells revealed reduced expression of T-bet, but not GATA-3 (Fig-
ure 3B). Notch had been shown to regulate Tbx21 in a GSI-
dependent manner and directly regulate Il4 via a 30 enhancer;
however, the GATA-3 result was unexpected because Notch
directly regulates Gata3 transcription by binding to the Gata3-
1a promoter in primary CD4+ T cells (Amsen et al., 2004, 2007;
Fang et al., 2007; Minter et al., 2005). When transcripts for
both Th1 and Th2 signature genes were analyzed by quantitative
PCR (qPCR), all four (Il4, Gata3-1a, Ifng, and Tbx21) were ex-
pressed at lower levels in DNMAML-expressing cells (Figure 3C).
The observed differences inGATA-3 protein expression between
GSI and DNMAML treatment were likely as a result of the finding
that GSI suppressed transcripts from both Gata3-1a and Gata3-
1b, whereas DNMAML only suppressed theGata3-1a transcript,
which accounts for a minor fraction of totalGata3 transcripts (Yu
et al., 2009) (Figures S2A and S2B). These data indicate that
Notch likely exerts its primary effect on the Th2 program through
its regulation of Il4. It is important to note that while DNMAML
expression had no impact on cell proliferation (Figure S2C), we
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Figure 2. Persistent Notch Signaling Is Required to Maintain the Th1 and Th2 Programs
WT naive CD4+ T cells were stimulated with irradiated splenocytes, anti-CD3ε, and anti-CD28, and cultured under neutral conditions. After 5 days, cells were
restimulated as above and replated in media containing either DMSO or 1 mMGSI. After 2 days (day 7 after activation), (A) RNA was then harvested and analyzed
by qPCR. Cells were analyzed for (B) cytokine production and (C) transcription factor expression by intracellular FACS.WT naive CD4+ T cells were stimulated and
cultured as above for 5 days in media containing either DMSO or GSI. Cells were then washed and restimulated under the same conditions, with cells previously
cultured in DMSO being replated in media containing DMSO and cells previously treated with GSI being replated in either DMSO or 1 mM GSI. After 2 days of
restimulation, (D) RNA was then harvested and analyzed by qPCR. Cells were analyzed for (E) cytokine production and (F) transcription factor expression by
intracellular FACS. *p < 0.05. Data are represented as mean ± SEM. See also Figure S1.
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Notch Functions in Helper T Cellsdid observe a minor increase in apoptosis as measured by
Annexin-V (Figure S2D). Although this subtle increase cannot
account for the marked reduction in cytokine transcript and
protein observed in DNMAML expressing cells, it suggests that
a role for Notch signaling in cell survival may also contribute to
these defects.
Our observation that both Th1 and Th2 cell signature genes
were sensitive to Notch inhibition in the same population sug-
gested that Notch does not instruct one program over the
other, but instead acts as a global regulator. This raised the
possibility that Notch could influence both Th1 and Th2 cell
signature genes, even in strongly polarizing conditions. In order
to assay direct Notch effects, we utilized the GSI-washoutassay (Weng et al., 2006). Notch targets are identified as
transcripts that demonstrate GSI sensitivity under mock wash
conditions and recover upon washout in the presence of
cycloheximide.
Naive CD4+ T cells were activated as described and cultured
under strong Th1 or Th2 cell polarizing conditions. As published,
both Il4 andGata3-1a behaved as direct Notch targets under Th2
cell polarizing conditions (Amsen et al., 2004, 2009; Fang et al.,
2007) (Figure 3D). Unexpectedly, both of these genes behaved
as direct Notch targets under Th1 cell polarizing conditions,
although the magnitude of their expression was greatly reduced,
likely as a result of suppression by Th1 cell culture conditions
(Figure 3D). Consistent with others (Minter et al., 2005), weImmunity 39, 148–159, July 25, 2013 ª2013 Elsevier Inc. 151
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Figure 3. Notch Concurrently Regulates Both the Th1 and Th2 Programs
YFPFL/FL or DNMAMLFL/FL CD4+ T cells were Tat-cre treated and rested for 24 hr in media containing 100 ng/mL IL-7. Naive CD4+ T cells were then FACS sorted
and stimulated with irradiated splenocytes, anti-CD3ε, and anti-CD28, and cultured under neutral conditions. After 5 days, (A) cytokine production wasmeasured
by intracellular FACS, (B) Tbet and GATA-3 protein wasmeasured by intracellular FACS, and (C) RNAwas analyzed by qPCR.WTCD4+ T cells were stimulated as
above and cultured under either Th1 or Th2 culture conditions. After 24 hr, cells were treated with either DMSO or GSI for 20 hr. Subsequently, T cells were CD4+
MACS purified and cells cultured in DMSO were replated in DMSO and cells cultured in GSI were either replated in GSI (Mock) or in DMSO (Washout) for 4 hr; all
cells were placed in media containing CHX.
(D) RNA was then harvested and analyzed by qPCR.
(E) WTCD4+ T cells were stimulated as above. After 2 days, cells were fixed andChIP was performedwith anti-Notch1 antibody, with Nanog serving as an internal
negative control. As a negative control for the assay and antibody, anti-Notch1 ChIP was performed on CD4-Cre3 Notch1FL/FL CD4+ T cells. *p < 0.05. Data are
represented as mean ± SEM. See also Figure S2, Table S1, and Table S2.
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Notch Functions in Helper T Cellsidentified Tbx21 as a direct Notch target in Th1 cell conditioned
cells but surprisingly also observed that Tbx21 behaved as a
direct Notch target even under Th2 cell polarizing conditions
(Figure 3D). To confirm the unbiased behavior of Notch under
polarizing conditions, we performed chromatin immunoprecipi-
tation (ChIP) assays. Consistent with GSI-washout results,
Notch1 bound the previously reported Il4 HS-V, Gata3-1a, and
Tbx21 Notch1 binding sites (Figure 3E). The magnitude of Notch
binding was similar in both Th1 and Th2 cell polarizing condi-
tions, suggesting that the polarizing conditions do not bias Notch
binding to these critical Th1 and Th2 cell targets. This is also how
endogenous Notch1 binds Tbx21 in primary cells, confirming
previous studies (Minter et al., 2005). Together with GSI-washout
data, our ChIP findings confirm that Notch concurrently regu-
lates both Th1 and Th2 programs, independently of cytokine
signals.152 Immunity 39, 148–159, July 25, 2013 ª2013 Elsevier Inc.Notch Simultaneously Orchestrates Multiple Th Cell
Programs by Sensitizing Cells to Exogenous Cytokine
Having observed that Notch regulates both Th1 and Th2 cell pro-
grams, we hypothesized that Notch could regulate these targets
in other Th cell populations, such as Th17 cells. To test this, we
activated naive CD4+ T cells as described, cultured under strong
Th17 cell differentiating conditions, and subjected to the GSI-
washout assay. Consistent with Th1 and Th2 cell observations,
Il4 and Tbx21 both behaved as direct Notch targets in Th17
polarized cells (Figure 4A);Gata3-1a transcript was undetectable
under these conditions (data not shown). To test whether Notch1
binding was conserved between Th1, Th2, and Th17 cells, we
performed ChIP analysis. In keeping with our GSI washout
observations, Notch1 bound to the Il4, Gata3-1a, and Tbx21
loci in Th17 polarized cells, demonstrating that even though
Gata3-1a was expressed at levels below the limit of detection,
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Figure 4. Notch Simultaneously Orchestrates Multiple Th Cell Programs
WT CD4+ T cells were stimulated as described under Th17 culture conditions.
(A) After 24 hr, cells were treated with either DMSO or GSI for 20 hr and then subjected to a GSI washout assay. Cells cultured in DMSO were replated in DMSO
and cells cultured in GSI were either replated in GSI (Mock) or in DMSO (Washout) for 4 hr. RNA was then harvested and analyzed by qPCR.
(B) After 2 days, cells were fixed and ChIP was performed with anti-Notch1 antibody, with Nanog serving as an internal negative control. Anti-Notch1 ChIP was
performed on CD4-Cre 3 Notch1FL/FL CD4+ T cells as an experimental and antibody negative control.
(C) A GSI washout assay was performed as above on activated CD4+ T cells cultured under either Th1, Th2, or Th17 polarizing conditions. At the end of the assay
(48 hr), RNA was harvested and analyzed by qPCR.
(D) Naive CD4+ T cells were FACS sorted from Tat-Cre treated YFPFL/FL or DNMAMLFL/FL CD4+ T cells. Cells were then stimulated as above, and cultured under
Th17 conditions. After 3 days, cytokine production was measured by intracellular FACS.
(E)WTCD4+ T cells were stimulated as described and then cultured in a titration series of two-fold serially diluted Th1 (left panel), Th2 (middle panel), or Th17 (right
panel) conditionedmedia, in the presence of either DMSOorGSI. After 5 days, cells were restimulated and supernatants were analyzed by ELISA 2 days later. *p <
0.05. Data are represented as mean ± SEM. See also Table S1 and Table S2.
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Notch Functions in Helper T CellsNotch still occupied this region. These data illustrate that
the concurrent regulation of Th cell programs by Notch is
not a unique feature of Th1 and Th2 cells but rather a con-
served function of Notch signaling in mature, activated CD4+
T cells.
To further demonstrate that Notch functions to regulate multi-
ple cell programs from a common progenitor, we assayed
whether the Th17 cell signature genes Il17a and Rorc behaved
as direct Notch targets, regardless of the cytokine environment.
Naive CD4+ T cells were activated as described, cultured under
Th1, Th2, or Th17 cell conditions, and subjected to the GSI
washout assay. Although the expression varied by condition,
Il17a and Rorc both behaved as direct Notch targets in all three
Th cell types (Figure 4C).
To confirm that the observed effects on Th17 cell signature
gene transcription were biologically significant, we expressedDNMAML in naive CD4+ T cells by using Tat-Cre, as described,
and activated them under Th17 differentiating conditions. We
observed at day 3 that DNMAML expression resulted in a
marked reduction in the frequency of IL-17A producing cells
(Figure 4D).
In light of reports showing that exogenous cytokine has the
capacity to rescue cytokine production in Notch loss-of-function
models (Amsen et al., 2004; Tu et al., 2005), we hypothesized
that an important function of Notch was to sensitize CD4+
T cells to polarizing factors, especially when these factors may
be limiting. To test this, we activated CD4+ T cells in the presence
of serially diluted Th1, Th2, or Th17 polarizing cytokines, with
media containing either DMSO or GSI. If Notch played a role in
sensitizing cells to exogenous cytokine, we would predict that
Notch inhibition would minimally affect differentiation at high
levels of differentiating factors but exert a negative effect onImmunity 39, 148–159, July 25, 2013 ª2013 Elsevier Inc. 153
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Figure 5. Notch Directly Regulates Ifng Expression
(A) WT CD4+ T cells were stimulated as described under either Th1, Th2, or Th17 culture conditions. 24 hr later, cells were treated with either DMSO or GSI for
20 hr and then subjected to a GSI washout assay. Cells cultured in DMSOwere replated in DMSO and cells cultured in GSI were either replated in GSI (Mock) or in
DMSO (Washout) for 4 hr. RNAwas then harvested and analyzed by qPCR.WT and T-bet KO naive CD4+ T cells were stimulated as above and cultured with IL-12
(5 ng/mL), anti-IL-4 (20 mg/mL), and anti-IFN-g (20 mg/mL). After 24 hr, cells were retrovirally transduced with either vector control (Mig) or DNMAML.
(B) Cytokine production was measured by intracellular FACS and (C) cytokine secretion by ELISA, 48 hr after transduction. *p < 0.05. Data are represented as
mean ± SEM.
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cells were cultured in the presence of DMSO, secretion of
IFN-g, IL-4, and IL-17A displayed an expected dose-dependent
response to polarizing cytokine, with maximal cytokine secretion
observed in undiluted differentiating media (Figure 4E). Consis-
tent with our hypothesis, when cells were cultured with GSI, cells
displayed similar levels of cytokine secretion to DMSO control
cells when differentiating cytokine was undiluted, but a much
more rapid and marked decay in cytokine secretion when differ-
entiating factors became limiting (Figure 4E). Altogether, these
findings demonstrate that Notch simultaneously orchestrates
multiple Th cell programs by sensitizing cells to exogenous
differentiating factors.
Notch Directly Regulates IFN-g Expression,
Independently of T-bet
Because Notch regulates a Gata3:Il4 axis in Th2 cells and an
Il17a:Rorc axis in Th17 cells, we hypothesized that Notch might
similarly regulate a Tbx21:Ifng axis in Th1 cells. To confirm that
Ifng is a direct Notch target, we performed a GSI washout assay
on cells cultured under strong Th1, Th2, and Th17 polarizing
conditions. Similar to Gata3-1a, Il4, and Tbx21, Ifng behaved
like a direct Notch target under all three culture conditions
(Figure 5A).
To exclude the possibility that effects of Notch on Ifng resulted
from indirect effects on Tbx21, we inhibited Notch signaling in
Tbx21/ cells. Naive CD4+ T cells from wild-type (WT) and
Tbx21/ mice were activated and retrovirally transduced with
vector control (MigR1) or DNMAML. To obtain sufficient IFN-g
expression in Tbet deficient cells, we cultured cells in the
presence of IL-12 and neutralizing anti-IFN-g and anti-IL-4
antibodies, conditions that allow Tbet-independent IFN-g
production (Schulz et al., 2009; Usui et al., 2006) and exclude
confounding paracrine effects between transduced and untrans-
duced cells. Transduction of either WT or Tbx21/ cells with
DNMAML decreased the fraction of cells producing IFN-g, as
well as the total amount of IFN-g secreted (Figures 5B and 5C).
Collectively, these data suggest that Notch directly regulates154 Immunity 39, 148–159, July 25, 2013 ª2013 Elsevier Inc.Ifng expression, independently of its role in regulating Tbx21,
and identify Ifng as a Notch target.
Notch1 Binds to the Ifng CNS-22
To determine the mechanism by which Notch directly regulates
Ifng, we searched for RBPJ binding sites in regions known to
be critical for Ifng transcription (Hatton et al., 2006). Three
RBPJ elements were identified in the Ifng CNS-22, a conserved
enhancer that is required for Ifng expression in T and NK cells
(Figure 6A) (Hatton et al., 2006). Primers were designed for
ChIP that flanked the strongest and most conserved RBPJ
binding site in the region. Two days after stimulation, CD4+
T cells exhibited Notch1 binding at the Ifng CNS-22 (Figure 6B).
Similar to Il4,Gata3-1a, and Tbx21 (Figure 3F), Notch1 bound the
Ifng CNS-22 site in Th1, Th2, and Th17 cells (Figure 6B).
Notch1 and Tbet Synergize to Drive Transcription from
the Ifng CNS-22
The observation that Notch1 binds the Ifng CNS-22 suggested
that Notch directly regulates Ifng expression through this
element. To test this, we utilized reporter constructs for the
Ifng CNS-22 region (Hatton et al., 2006). These constructs
contain either the minimal 468 bp Ifng promoter (ProWT) or this
promoter with the Ifng CNS-22 placed upstream (CNSWTProWT).
Two putative T-box half-sites were identified in the Ifng CNS-22
fragment and mutant constructs were generated to both the
upstream (CNSMT1ProWT) and downstream (CNSMT2ProWT)
T-box half-sites (Figure 7A) (Hatton et al., 2006). Although the
CNSMT2ProWT construct was originally described as a T-bet
binding site mutant, this same mutation also ablates the most
highly conserved RBPJ binding site in Ifng CNS-22. To test
whether Notch was capable of driving transcription through the
Ifng CNS-22 at this site in cells capable of endogenous IFN-g
production, we transfected activated Jurkat cells with vector
control (pcDNA) or the constitutively active Notch1 intracellular
domain ICN1 (Aster et al., 2000), as well as a reporter containing
pGL3, ProWT, CNSWTProWT, or CNSMT2ProWT (Figure 7B). Addi-
tion of CNSWTProWT resulted in slightly increased reporter
BA 1.00
0.75
0.50
0
0.25
Ifng CNS -22 kb
Ch
IP
 (
% 
of
 in
pu
t)
Nanog
Notch1-/-
Th1
Th2
Th17
Figure 6. Notch Binds to the Ifng CNS-22
(A) Multiple species alignment of the Ifng CNS-22 region, with NCBI http://dcode.org. Highly conserved RBPJ binding sites are highlighted. Primer sequences
used for ChIP are underlined.
(B) WT CD4+ T cells were stimulated as described and cultured under Th1, Th2, or Th17 conditions. After 2 days, cells were fixed and ChIP was performed with
anti-Notch1 antibody, with Nanog serving as an internal negative control. Anti-Notch1 ChIP on CD4-Cre3 Notch1FL/FL CD4+ T cells served as a negative control
for the antibody and assay. Data are represented as mean ± SEM.
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suggesting that Notch has the capacity to act on this enhancer
element. When CNSMT2ProWT was used, the increased activity
observed from the CNSWTProWT was lost and the addition of
ICN1 failed to enhance reporter activity (Figure 7B). These data
suggest that Notch1 is capable of enhancing transcription
through the Ifng CNS-22.
Although the Jurkat cell data established that Notch1 can drive
transcription from the Ifng CNS-22 in a mature T cell line, it
remained possible that Notch1 indirectly enhanced luciferase
activity by promoting Tbx21 transcription. In addition, the loss
of luciferase activity observed when CNSMT2ProWT was ex-
pressed may have resulted from a loss of T-bet binding, rather
than the loss of RBPJ binding at the same site. To test these
alternate hypotheses, we utilized U2OS cells, which do not ex-
press endogenous Tbx21 and express very low amounts of
Notch1 (data not shown). U2OS cells were transfected with the
reporter constructs described above as well as CNSMT1ProWT,
which ablates the upstream T-box half-site without disrupting
the RBPJ binding site. T-bet overexpression in U2OS cells
increased luciferase activity in all constructs (Figure 7C). This
effect appeared primarily as a result of T-bet activity on the
Ifng minimal promoter because the addition of the Ifng CNS-22
and mutation of either T-box half-site had no additional effect
on reporter activity (Figure 7C).
In contrast to Jurkat cells, ICN1 did not increase luciferase
activity in U2OS cells, suggesting that other factors endogenous
to Jurkat cells, such as T-bet, may be required to cooperate with
Notch1 activity. Accordingly, coexpression of T-bet and ICN1
synergistically increased luciferase activity from CNSWTProWT.
Moreover, the enhanced luciferase activity was specific to
CNSWTProWT and was not observed with ProWT, suggesting
that the synergy between Notch1 and T-bet resulted from
Notch1 activity at the Ifng CNS-22 (Figure 7C).
To directly address this possibility, we utilized the con-
struct in which the upstream T-box half-site was mutated
(CNSMT1ProWT). In cells expressing this reporter, luciferase
activity was similar to the CNSWTProWT under all conditions, sug-
gesting that the primary effect of T-bet was through its activity on
the promoter. In contrast, when the conserved RBPJ binding site
wasmutated (CNSMT2ProWT), luciferase activity was comparableto the ProWT construct (Figure 7C). Collectively, these data sug-
gest that ICN1 acts at the Ifng CNS-22 enhancer and T-bet acts
at the Ifng promoter.
To directly assay the site of T-bet activity, we mutated the
T-box site in the Ifng promoter, leaving the putative T-box sites
in the CNS-22 intact (Tong et al., 2005) (Figure 7A). When
U2OS cells were transfected with ProMT, neither T-bet alone
nor T-bet plus ICN increased reporter activity to that observed
in ProWT (Figure 7D). Moreover, mutation of the promoter in the
context of CNS-22 (CNSWTProMT) ablated the ability of either
T-bet alone or T-bet plus ICN1 to increase reporter activity (Fig-
ure 7D). Overall, these data demonstrate that binding of Notch at
the Ifng CNS-22 is insufficient to activate transcription by itself
and that Tbet binding at the promoter leads to weak activation;
however, the combination of Notch binding to the CNS-22 and
Tbet binding to the Ifng promoter leads to a synergistic increase
in Ifng transcription (Figure 7E).
DISCUSSION
Within the lymphoid compartment, Notch is understood to selec-
tively promote one lineage outcome at the expense of alternate
fates (Radtke et al., 2010). This instructive paradigm was pro-
posed to explain Th cell differentiation; however, the emerging
data are difficult to reconcile with this model because Notch pro-
motes mutually exclusive cell fates from a multipotential cell
(Amsen et al., 2004; Keerthivasan et al., 2011; Maekawa et al.,
2003; Minter et al., 2005; Mukherjee et al., 2009; Tu et al.,
2005). Here, we present data demonstrating that Notch acts as
an unbiased amplifier of the Th1, Th2, and Th17 cell programs
by sensitizing cells to environmental signals.
By acutely inhibiting Notch signaling under neutralizing condi-
tions, we reveal a role for Notch in simultaneously orchestrating
both Th1 and Th2 programs. GSI treatment and acute DNMAML
expression synchronously reduced IL-4, IFN-g, and T-bet pro-
tein and mRNA for Il4, Ifng, Tbx21, andGata3-1a, demonstrating
that Notch lacks selectivity in regulating critical Th cell program
targets. We further observed that Notch regulates Th17 target
genes even when their expression is suppressed under Th1
and Th2 conditions and vice versa. Although the polarizing con-
ditions influence the magnitude of gene expression, the ability ofImmunity 39, 148–159, July 25, 2013 ª2013 Elsevier Inc. 155
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Figure 7. Notch1 and Tbet Synergize to Drive Transcription from the Ifng CNS-22
(A) Schematic of the luciferase constructs used, as detailed in the methods.
(B) We transfected 23 105 Jurkat cells with renilla control (pRLTK), either the ProWT, ProWTCNSWT, or ProWTCNSMT2 luciferase reporter constructs, and either a
vector control or ICN1, with DMRIE-C liposomes. After 20 hr, cells were stimulated with PMA and ionomycin for 4 hr. Cells were then washed and luciferase
activity was measured.
(C) We transfected 23 104 U2OS cells with pRLTK, either the promoter ProWT, ProWTCNSWT, ProWTCNSMT1, or ProWTCNSMT2 reporter constructs, ICN1 or vector
control, and Tbet or vector control. After 48 hr, luciferase activity was measured.
(D) We transfected 23 104 U2OS cells with pRLTK, either the ProWT, ProMT, ProWTCNSWT, or ProMTCNSWT reporter constructs, ICN1 or vector control, and Tbet
or vector control. After 48 hr, luciferase activity was measured.
(E) Proposedmodel of Ifng loci regulation by Notch1 and Tbet. All values are normalized to the pGL3 control construct. Relative luciferase units were calculated by
normalizing firefly activity to renilla activity and setting all values relative to the pGL3 control construct. *p < 0.05. Data are represented as mean ± SEM.
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cytokine environment does not impact the ability of Notch to
regulate its targets. Accordingly, our work suggests that Notch
plays a critical role in reinforcing Th cell differentiation at physio-
logic levels of cytokine signaling, which would be important early
during immune responses when differentiating cytokine cues are
limiting. In addition, these findings help reconcile conflicting
reports in the literature that emphasized the ability of Notch to
preferentially regulate specific Th programs.
In relatedwork, Ong et al. contended that Notch signaling itself
had minimal impact on Th differentiation, but rather upstream
cytokine signals directed Notch to selectivity enhance individual
Th responses (Ong et al., 2008). Consistent with our findings,
these studies argued that Notch lacks instructive capacity. Our
T. muris studies provide the first in vivo loss-of-function data
confirming that Notch is not required for instruction; however,
our GSI-washout and ChIP data provide a distinct mechanistic
view of Notch function during Th differentiation. Rather than
requiring cytokine signals to condition Notch selectivity, we156 Immunity 39, 148–159, July 25, 2013 ª2013 Elsevier Inc.find that Notch binds and regulates target loci without regard
to cytokine signals. Moreover, we further show that Notch
concurrently regulates Th cell programs even under neutralizing
conditions. Thus, our work suggests that the activity of Notch is
not dictated by cytokine signaling but rather that Notch simulta-
neously facilitates transcription of multiple programs regardless
of polarizing cues.
In addition to providing a unifyingmodel for Notch in Th cell dif-
ferentiation, we present definitive genetic loss-of-function and
molecular data evincing a role for Notch in the Th1 program.
Not only do our data demonstrate for the first time that endoge-
nous Notch1 binds Tbx21 and that Tbx21 is a direct Notch target
in primary CD4+ T cells, but we also show that Ifng is a direct
Notch target, independent of Notch’s role in regulating Tbx21.
Although the Notch effects on Ifng are independent of its activity
on Tbx21, Notch does not appear capable of driving Ifng tran-
scription by itself, consistent with a model in which Notch lacks
the capacity to instruct Th differentiation. Both factors are
needed for optimal Ifng expression, where they bind different
Immunity
Notch Functions in Helper T Cellsregulatory elements. Moreover, the Tbx21/ studies suggest
that Notch is capable of collaborating with factors other than
T-bet because DNMAML suppressed Ifng expression in its
absence. The original report with these luciferase constructs
found that T-bet overexpression was capable of enhancing lucif-
erase activity of the WT CNS-22 construct when cells were stim-
ulated with PMA and ionomycin (Hatton et al., 2006), which also
induces NF-kB binding to the IfngCNS-22 (Balasubramani et al.,
2010). Because the Ifng CNS-22 contains multiple regulatory
motifs, these data suggest that T-bet activity at the Ifng promoter
synergizes with multiple factors regulating the Ifng CNS-22,
including Notch and NF-kB. Altogether, these data illustrate
the dynamism of the Ifng promoter and CNS-22 and demon-
strate how these elements have the potential to integrate inputs
from multiple pathways.
The results of our reporter assays are reminiscent of the syn-
ergy between GATA-3 and Notch1 at the Il4 locus and suggest
that Notch and cytokine signaling collaborate in both Th1 and
Th2 differentiation (Fang et al., 2007). Furthermore, Notch
appears to participate in a feedforward loop, promoting Tbx21
transcription and in turn synergizing with T-bet protein to
enhance Ifng transcription. Work by Flavell and colleagues sug-
gests that this Th1 feedforward loop must be stabilized by other
factors (Amsen et al., 2007). In their study, constitutive Notch
signaling was insufficient to enforce Th1 differentiation in the
presence of endogenous GATA-3, demonstrating that low levels
of GATA-3 act as a failsafe against runaway Th1 differentiation in
response to Notch activation. In addition to transcriptional regu-
lation, Notch can regulate IFN-g secretion in an RBPJ-indepen-
dent manner, suggesting that Notch regulates the CD4+ T cell
IFN-g response at multiple, mechanistically distinct levels
(Auderset et al., 2012). Additionally, a recent human T cell study
implicated a role for Notch in Th1 differentiation (Le Friec et al.,
2012). Together, these data firmly establish Notch as a key
regulator of the Th1 program.
As well as revealing a definitive role for Notch in promoting
Th1 differentiation, our data further clarify the mechanism by
which Notch regulates Th2 differentiation. The findings from
anti-IFN-g mAb treated T muris-infected CCD mice indicate
that the role of Notch during in vivo Th2 inflammation is similar
to what has been reported for NF-kB2, IL-25, and TSLP (Artis
et al., 2002; Owyang et al., 2006; Taylor et al., 2009). Like
Notch, mice deficient for each of these factors displayed sus-
ceptibility to helminth infection and impaired Th2 immune
responses; however, blockade of Th1 responses in these
mouse models resulted in restoration of the Th2 response and
worm expulsion. Moreover, unlike the role for Notch in regu-
lating Th1 differentiation, we observe a major role for Notch in
promoting IL-4 production but minimal impact on total
GATA-3, suggesting that additional factors, such the Notch
target Tcf1, may be required to fully engage the Th2 program
(Yu et al., 2009). These studies collectively illustrate a clear
distinction between Th2 initiating factors, such as NF-kB1 (Artis
et al., 2002), and the multiple inputs that maintain an optimal
Th2 response in vivo but are dispensable for Th2 program initi-
ation, such as Notch.
In addition to regulating Notch-dependent IL-4 production in
Th2 cells, recent work demonstrated that the IL-4 HS-V region
is critical for T follicular helper cell (Tfh) production of IL-4(Harada et al., 2012; Vijayanand et al., 2012). These findings
raise the possibility that Notch inhibition in the T. muris studies
may impact both Th2 and Tfh subsets during infection and the
combined effects on these two populations contribute to
the phenotype observed. Importantly, anti-IFN-g treatment
restored productive immunity against helminth infection; and
therefore, the role that Notch signaling plays in Tfh biology is
either redundant with its function in Th2 cells or not essential
for Tfh differentiation, similar to what we observe for Th1,
Th2, and Th17 subsets.
With the recent recognition of Th cell plasticity, particularly at
early time points, our data suggest that Notch functions to
ensure that activated CD4+ T cells overcome a Th cell commit-
ment threshold (Murphy and Stockinger, 2010). In this manner,
Notch tunes the responsiveness of an activated CD4+ T cell to a
specific Th cell program by sensitizing cells to limiting environ-
mental differentiation cues. Thus, depending on the inflamma-
tory environment for a given immune response, the requirement
for Notch will vary depending on whether the strength of the
differentiating signals a T cell receives are sufficient to achieve
a signaling threshold for Th cell commitment. For example, dur-
ing T. muris infection, our model argues that Notch sensitizes
T cells to limiting Th2 differentiating cues, whereas residual
IFN-g signals destabilize the Th2 circuitry when Notch signaling
is abrogated. This model would also explain why Th1 differenti-
ation occurs independently of Notch during Leishmania infec-
tion because we would predict that the environmental differen-
tiating signals are sufficient to overcome a commitment
threshold (Amsen et al., 2004; Tu et al., 2005). Alternatively, in
the context of GvHD, which is characterized by a mixed Th
cell response, Notch is required to sensitize cells to subthresh-
old signals and achieve optimal IFN-g production (Zhang et al.,
2011). Although our data favor a model in which Notch regu-
lates Th differentiation by sensitizing cells to their environment,
Notch likely plays additional roles in other aspects of Th
biology, such as survival and metabolism, that warrant future
study.
Overall, these findings offer a paradigm for Notch in the
immune system. In addition to its roles as an arbiter of alternate
fate decisions and a key regulator of cell survival, proliferation,
and metabolism, we reveal that Notch also acts to potentiate
multiple fates from a single progenitor. Not only does this para-
digm reconcile previously conflicting studies, but it also sug-
gests that manipulating the amounts of Notch signaling in Th
cell-mediated pathologies may have therapeutic benefit.
EXPERIMENTAL PROCEDURES
Mice
ROSA26-DNMAML mice were previously described (Tu et al., 2005). C57Bl/6
mice were obtained from the National Cancer Institute (Frederick, MD).
YFP mice were obtained from Jackson Laboratories (Bar Harbor, ME).
Tbx21/ mice were provided by John Wherry. All mice were housed in spe-
cific pathogen-free facilities at the University of Pennsylvania. Experiments
were performed according to the guidelines from the National Institutes of
Health (NIH) with approved protocols from the University of Pennsylvania
Animal Care and Use Committee.
TAT-Cre
Expression of TAT-cre was induced with IPTG in bacteria during log phase of
growth at 37C in the presence of chloramphenicol and carbenicillin. TheImmunity 39, 148–159, July 25, 2013 ª2013 Elsevier Inc. 157
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TAT-Cre protein. We MACS purified 107 CD4+ T cells from DNMAMLFL/FL or
YFPFL/FL mice by positive selection with CD4 Microbeads (Miltenyi). Subse-
quently, cells were washed, resuspended in 1 ml serum-free OPTI-MEM
(Life Technologies), and incubated with 1 ml of 100 mg/ml of TAT-Cre in
OPTI-MEM for 12 min at 37C. Cells were then washed and cultured in
IMDM (Life Technologies) supplemented with 10% heat-inactivated FBS,
100 U/ml penicillin, 100 mg/ml streptomycin, 2 mM L-glutamine, 50 mM
2-mercaptoethanol, and 100 ng/mL IL-7. Twenty-four hours later, naive
YFP+ or GFP+ CD4+ T cells were FACS sorted.
Quantitative PCR
RNA was extracted with the QIAGEN RNeasy Mini Kit. cDNA was synthesized
from RNA with the Superscript II kit (Invitrogen). Transcripts were amplified
with Sybr Green PCR Master Mix (ABI) and quantitative PCR was performed
on an ABI ViiA 7 real-time PCR System. (Primers, Table S1).
Chromatin Immunoprecipitation Assays
ChIP was performed as described previously (Yashiro-Ohtani et al., 2009).
Briefly, chromatin samples were prepared from fixed 6 million cells and immu-
noprecipitated with rabbit immunoglobulin G (#sc-3888; Santa Cruz Biotech-
nology, Santa Cruz, CA) or anti-Notch1 antibodies (Aster et al., 2000). Purified
DNA was subjected to real-time PCR with primers flanking RBPJ binding sites
at Gata3-1a, Il4 HS-V, IFNg CNS-22, or Tbx21 promoter (primers, Table S2).
CD4+ T cells from Notch1 null mice were used for an immunoprecipitation
negative control. Nanog was used as an internal negative control. The DNA
quantity recovered from each ChIP sample is shown as the relative value to
the DNA input sample. Table S1 lists primer sequences.
Luciferase Assay
Ifng luciferase constructs are described (Hatton et al., 2006). Constructs
included a reporter control (pGL3), the reporter plus a 468 bp Ifngminimal pro-
moter (ProWT), the minimal promoter construct containing a mutated T-box
binding site (ProMT), the minimal promoter construct with a WT Ifng CSN-22
upstream (ProWTCNSWT), the WT CNS-22 construct containing a mutated T-
box binding site in the promoter region (ProMTCNSWT), the Ifng CNS-22
construct with the upstream CNS-22 T-box half-site mutated (ProWTCNSMT1),
and the Ifng CNS-22 construct with the downstream CNS-22 T-box half-site
mutated (ProWTCNSMT1). Point mutations to T-box binding sites in the Ifng pro-
moter were made with the Promega QuikChange Site Directed Mutagenesis
Kit. Constructs were sequenced to prove authenticity. We plated 2 3 105
Jurkat cells in triplicate and transfected with 50 ng of the indicated reporter
constructs, 25 ng pRL-TK, and 100 ng pcDNA-ICN1 or vector control with
DMRIE-C (Invitrogen). Transfected cells were cultured overnight and then
stimulated for 4 hr with 20 ng/mL PMA and 200 ng/mL ionomycin. We plated
23 104 U2OS cells in triplicate and transfected with 50 ng of the indicated re-
porter constructs, 10 ng pRL-TK, 10 ng pcDNA-ICN1 or vector control, and
25 ng Mig-Tbet or vector control with FuGENE 6 (Promega). After stimulation,
firefly substrate activity was measured with Britelite Plus (PerkinElmer) and re-
nilla substrate activity measured with Stop & Glo (Promega). Firefly values
were normalized to Renilla and then all normalized values set relative to the
pGL3 control vector. All measurements were performed with a GloMax-96 Mi-
croplate Luminometer (Promega).
In Vitro T Cell Culture
Lymph nodes from WT mice were CD4+ MACS purified and then naive CD4+
T cells were FACS sorted. Naive CD4+ T cells were cocultured with irradiated,
Thy1.2 depleted splenocytes at a 1:5 ratio and stimulatedwith anti-CD3e (1 mg/
mL), and anti-CD28 (1 mg/mL) mAb. Cells were cultured under either neutral
(5 ng/mL IL-2, 20 mg/mL anti-IL-4, and 20 mg/mL anti-IFN-g), Th1 (5 ng/mL
IL-2, 5 ng/mL IL-12, and 20 mg/mL anti-IL-4), Th2 (20 ng/mL IL-4,
20 mg/mL anti-IFN-g, and 20 mg/mL anti-IL-12), or Th17 (20 ng/mL IL-6 and
5 ng/mL TGF-b) culture conditions. For GSI experiments, cells were treated
with either DMSO or 1 mM GSI.
Measurement of Cytokines
For intracellular cytokine staining, cells were restimulated, fixed, and stained
as described (Tu et al., 2005). Cells were stained with anti-CD4 (RM4-5, Bio-158 Immunity 39, 148–159, July 25, 2013 ª2013 Elsevier Inc.legend), anti-IFN-g (XMG1.2, BD), anti-IL4 (11B11, eBioscience), anti-IL17A
(ebio17B7, eBioscience), anti-Tbet (eBio4B10, eBioscience), and anti-GATA-
3 (L50-823, BD). Cells were acquired on a LSRII (Becton Dickenson) and
data was analyzed with FlowJo (TreeStar). ELISA was performed as described
(Tu et al., 2005).
GSI-Washout Assay
WT CD4+ T cells were stimulated as above and 24 hr after stimulation cells
were treated with either DMSO or GSI (1 mM) for 20 hr. Subsequently, T cells
were CD4+ MACS purified and cells cultured in media containing cyclohexi-
mide (20 mg/mL) and cells previously cultured DMSO were replated in
DMSO and cells cultured in GSI were either replated in 1 mM GSI or in
DMSO for 4 hr. RNA was then harvested and analyzed by qPCR.
T. muris Infection and Antigen
T. muris eggs were prepared as described (Tu et al., 2005). Mice were infected
on day 0 with 150–200 embryonated eggs, and parasite burdens were
assessed on day 21 after infection. Mesenteric LN (MLN) cell suspensions
were prepared and resuspended in IMDM supplemented with 10% heat-inac-
tivated FBS, 100 U/ml penicillin, 100 g/ml streptomycin, 2 mM L-glutamine,
and 50 M 2-mercaptoethanol. Cells were plated at 4 3 106 cells per well and
cultured in the presence of anti-CD3e and anti-CD28 for 72 hr. Levels of IL-
4, IL-5, and IL-13 were assayed by sandwich ELISA. For histology, segments
of midcecumwere removed, washed in sterile PBS, and fixed for 24 hr in para-
formaldehyde. Tissues were processed and paraffin embedded with standard
histological techniques. For detection of intestinal goblet cells, 5 mm sections
were cut and stained with hematoxylin and eosin or Alcian blue periodic acid
Schiff. Analysis of parasite- specific IgG1 and IgG2c production was per-
formed by antigen capture.
Statistical Analysis
Significance was determined with a Student’s t test. A p value of less than 0.05
was considered statistically significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes twofigures and two tables andcanbe found
with this article online at http://dx.doi.org/10.1016/j.immuni.2013.07.006.
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